{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:59:48Z","timestamp":1790002788499,"version":"4.0.1"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,21]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To determine whether recurrence burden in branch retinal vein occlusion-related macular edema (BRVOME) reflects longitudinal foveal avascular zone (FAZ) enlargement or baseline inter-eye superficial microvascular disparity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective, paired-eye longitudinal study included consecutive treatment-na\u00efve unilateral BRVOME eyes. Optical coherence tomography angiography (OCTA) was performed at the first visit after complete resolution of ME following anti-vascular endothelial growth factor (anti-VEGF) therapy (baseline) and at 1 year. FAZ areas in superficial and deep capillary plexuses (SCP and DCP) were quantified in both BRVO and fellow eyes. Inter-eye FAZ disparity (\u0394FAZ = BRVO - fellow) was calculated. Recurrence burden was defined as the number of intravitreal anti-VEGF injections during 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Sixty-nine eyes were analyzed. SCP and DCP FAZ areas were significantly larger in BRVO than in fellow eyes at baseline and remained larger at 1 year (both p &lt; 0.001). Longitudinal FAZ enlargement was not associated with recurrence burden. Baseline \u0394SCP was independently associated with higher recurrence burden. Each 0.1-mm\n                      <jats:sup>2<\/jats:sup>\n                      increase in baseline \u0394SCP was associated with an 8% increase in recurrence burden [incidence rate ratio, 1.08; 95% confidence interval, 1.01 - 1.16; p = 0.022]. Baseline \u0394DCP was not associated with recurrence frequency.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Recurrence burden in BRVOME was associated with baseline superficial FAZ disparity rather than longitudinal FAZ progression. Baseline \u0394SCP showed only modest discriminative ability and should be interpreted as one component of a broader microvascular risk profile rather than a standalone biomarker for recurrence prediction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000005016","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:01:23Z","timestamp":1789999283000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Baseline Superficial FAZ Disparity Is Associated With Recurrence in Branch Retinal Vein Occlusion-related Macular Edema"],"prefix":"10.1097","author":[{"given":"Taiichi","family":"Hikichi","sequence":"first","affiliation":[{"name":"Hikichi Eye Clinic, Sapporo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000005016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:01:23Z","timestamp":1789999283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000005016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000005016","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}